Aton Ra Partners Catalent, Inc. Transaction History

Aton Ra Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$45.44 - $74.26 $37,533 - $61,338	-826 Reduced 9.31%	8,049 $528,000
Q4 2022 Feb 02, 2023	SELL	$41.39 - $81.0 $142,961 - $279,774	-3,454 Reduced 28.02%	8,875 $399,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $6,222 - $9,726	86 Added 0.7%	12,329 $892,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $860,664 - $1.13 Million	-9,870 Reduced 44.63%	12,243 $1.31 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $22,228 - $29,379	236 Added 1.08%	22,113 $2.45 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $246,075 - $286,206	2,058 Added 10.38%	21,877 $2.8 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $68,667 - $89,538	629 Added 3.28%	19,819 $2.64 Million
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $1.93 Million - $2.22 Million	19,190 New	19,190 $2.08 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.